Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan

References

• Harrington J. Developmental issues in adolescence and the impact of rheumatic disease. In: Isenberg DA, Miller JJ, editors. Adolescent rheumatology. London: Martin Dunitz; 2000. p. 21� 34.
   Google Scholar
• Petty RE, Cassidy JT. Chronic arthritis, poly arthritis, oligoarthritis, systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Linsley CB, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005. p. 206�303.
   Google Scholar
• Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn. 1997;39:242�4.
   Google Scholar
• Yokota S. Investigation of the actual situation and medical administrative policy for QOL improvement in patients with juvenile rheumatoid arthritis. Public Welfare Labor Science Study, 2000.
   Google Scholar
• Hollingworth P. The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases. Br J Rheumatol. 1993;32:73�7.
   Google Scholar
• Cassidy JT. Outcomes research in the therapeutic use of methotrexate in children with chronic peripheral arthritis. J Pediatr. 1998;133:179�80.
   Google Scholar
• Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child. 2003;88:197�200.
   Google Scholar
• Yokota S. Classification and treatment strategy for juvenile idiopathic arthritis. Therapy. 1999;81:766�72.
   Google Scholar
• Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children�s Study Group. N Engl J Med 1992; 326: 1043�9.
   Google Scholar
• Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J, et al. Randomized, placebo-controlled, crossover trial of lowdose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000;43:1849�57.
   Google Scholar
• National Institute for Clinical Excellence March 2002. Technology Appraisal No. 35. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. http://www.nice.org.uk/.
   Google Scholar
• Past package inserts for Rheumatrex Capsule 2 mg. Revised February 2007.
   Google Scholar
• Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552�63.
   Google Scholar
• Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic diseases. Ann Rheum Dis. 2000;59\(Suppl 1):21�27.
   Google Scholar
• Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763�9.
   Google Scholar
• Brewer EJ Jr, Giannini EH. Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design. J Rheumatol. 1982;9:109�13.
   Google Scholar
• Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, et al. Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med. 2005;352:1655�66.
   Google Scholar
• Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004;50:2191�201.
   Google Scholar
• Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202�9.
   Google Scholar
• Ruperto N, Ravelli A, Falcini F, Lepore L, De Sanctis R, Zulian F, et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis. 1998;57:38�41.
   Google Scholar
• Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol. 1997;24:2230�2.
   Google Scholar
• Balis FM, Savitch JL, Bleyer WA. Pharmacokinetics of oral methotrexate in children. Cancer Res. 1983;43:2342�5.
   Google Scholar
• Ravelli A, Di Fuccia G, Molinaro M, Ramenghi B, Zonta L, Regazzi MB, et al. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. J Rheumatol. 1993; 20:1573�7.
   Google Scholar
• Albertioni F, Flato B, Seideman P, Beck O, Vinje O, Peterson C, et al. Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics. Eur J Clin Pharmacol. 1995; 47:507�11.
   Google Scholar
• Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol. 1990;17:1469�73.
   Google Scholar
• Pinkerton CR, Welshman SG, Glasgow JF, Bridges JM. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet. 1980;2:944�6.
   Google Scholar
• Dupuis LL, Koren G, Silverman ED, Laxer RM. Influence of food on the bioavailability of oral methotrexate in children. J Rheumatol. 1995;22:1570�3.
   Google Scholar
• Bannwarth B, Pehourcq F, Lequen L. Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications. Therapie. 1997;52:129�32.
   Google Scholar
• Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1989;32:677�81.
   Google Scholar
• Kasapcopur O, Cullu F, Kamburoglu-Goksel A, Cam H, Akdenizli E, Calykan S, et al. Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis. 2004;63:1128�30.
   Google Scholar
• Takken T, Van Der Net J, Helders PJ. Methotrexate for treating juvenile idiopathic arthritis. Cochrane Database Syst Rev 2001: CD003129.
   Google Scholar
• Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1993;23:34�46.
   Google Scholar
• Ravelli A, Martini A. Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol. 2000;27:1830�3.
   Google Scholar
• Yokota S. Recent topics on rheumatism and collagen diseases in childhood. Nippon Naika Gakkai Zasshi 2007; 96: 2226�34 (in Japanese).
   Google Scholar
• Aihara Y, et al. The MTX therapy for juvenile idiopathic arthritis. Ryumach 40: 336, 2000 (Proceedings of the 44th meeting of the Japan College of Rheumatology) (in Japanese).
   Google Scholar
• Nelson Textbook of Pediatrics (17th editon, 2004) Chapter 114 http://www.mdconsult.com/das/book/0/view/1175/instruct.html.
   Google Scholar
• Proper use information for Rheumatrex Capsule 2 mg (vol 12): Reexamination application material (Use Result Surveillance and Special Use-Result Surveillance), prepared in January 2007.
   Google Scholar
• Proper use information for Enbrel Subcutaneous injection 25 mg (vol 6): all cases surveillance interim report II (n - 7,091 cases), prepared in June 2007.
   Google Scholar
• Kawai S, Ochi T, Kondo H, Nishioka K, Nobuyuki N, Yoshino S. A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis. Ryumachi 2002; 42: 76�9 (in Japanese). Mod Rheumatol (2009) 19:1�11 11
   Google Scholar